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After the ofﬁcial opening of the meeting by Ian
Jackson (MRC Human Genetics Unit, UK), John
McPherson (Washington University, USA) gave his
plenary lecture Mapping and sequencing the mouse
genome. He started with a report on the status of
‘the other genome’ (human), stating that they now
have y2.9 Gb of sequence, 1.75 Gb of which is
‘ﬁnished’ and 99% of which is aligned to the
chromosomes. Chromosomes 22, 21, 20 and Y are
complete; chromosomes 6, 7 and 14 are nearing
completion. In spring, the mouse genome sequen-
cing consortium achieved their initial aim of 2–3X
coverage, they are now doing more shotgun
sequencing with the aim of reaching 5–6X coverage.
This data will be better for assembly and regula-
tory element discovery purposes. They are using a
combination of whole genome and BAC shotgun
data, but have not as yet decided on the optimal
ratio. They anticipate being able to increase the
amount of machine time spent on mouse as the
human genome is completed. Their BAC ﬁnger-
printing is done using highly controlled, repro-
ducible gels; markers are then used to build the
map up from the binning data provided by the FPC
program. The contigs are then mapped onto the
mouse radiation hybrid map and the human draft,
which has also helped with gap length estimation.
The map currently consists of 300 000 clones in
>700 contigs and should be ﬁnished by the end
of this year. There are currently two BAC maps,
one made at Washington University (http://genome.
wustl.edu/gsc/mouse) and one at the Sanger Centre.
The mouse genome data is beneﬁting from annota-
tion and display right from the start, unlike the
human genome data (http://mouse.ensembl.org).
Ensembl mouse uses the Sanger map and includes
comparisons with the human data. Work is under-
way to link the mouse and human Ensembl
resources to allow users to move between the two
genomes. They are aiming for >99% coverage by
early 2003 and a complete draft by 2005. There is
also a SNP discovery project using a selection of
strains, which it is hoped will identify 50 000 SNPs.
Genome sequencing and comparative
analysis
Kerstin Lindblad Toh (Whitehead Institute, USA)
spoke about the status of the mouse genome
sequence. At the moment the data stands between
2.75 and 3 Gb, which equates to 2.7X coverage. The
sequence has been assembled into 650 000 contigs
with an average length of 4.8 kb, 87% of these are
anchored onto the BAC map. By February or
March they hope to have 40 million reads and
y90–95% of the data anchored onto the map. The
Homology Group at the Whitehead Institute have
been looking at sequence conservation, using a
selection of programs including GenScan, Genome-
Scan and TwinScan. Using TwinScan they think
that they will ﬁnd between 400 and 5000 new
human genes. Of the 3% of sequence which is
conserved yhalf is coding and half is non-coding.
The non-coding matches are typically 150–170 bp
long and seem not very different from the coding
matches. Many of them are within 1 kb upstream of
genes and some are in introns. They have managed
to cluster some of them and plan to further
investigate the clusters.
Shaying Zhao (TIGR, USA) described the work
at TIGR on their mouse and rat BAC end sequen-
cing projects. For mouse they have two clone
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(200 kb and 160 kb). They have sequenced over
400 000 ends from y250 000 clones from the two
collections. Their average read length is y500 bp
and they have sequenced both ends of y190 000
clones. These have been assembled into contigs, and
mapping the contigs onto the human draft genome
has shown that they have a good spread of
coverage. The rat project also uses two resources
of BACs, this project is less complete and is still
ongoing. So far they have sequenced at least one
end of 47 000 clones from one resource and have
36 000 paired ends. The goal is to generate paired
ends from 200 000 rat BACs in one year.
Muriel Davisson (Jackson Laboratory, USA)
discussed their comparison of human chromosome
21 with mouse chromosomes 16 and 17. 60–70% of
human chromosome 21 (from the centromere down)
is conserved in mouse on distal chromosome 16, the
remainder (working towards the telomere) is con-
served in mouse on chromosomes 17 and 10. This
group is interested in the region associated with
Down syndrome; a mouse Down syndrome trisomy
model that they have developed has a small extra
chromosome with some of chromosome 16 and
some of chromosome 17. They are sequencing these
regions and have assigned many new genes to the
two chromosomes. They have also identiﬁed the
genes on human chromosome 21 which delineate
the evolutionary breakpoints for the mouse chromo-
somes. In comparing human chromosome 21 with
mouse 16, they have seen that of 91 orthologues,
only one differs in gene order. There appear to
be a few ‘human speciﬁc’ genes but these could lie
in gaps in the mouse data. There are also a few
apparently mouse speciﬁc genes, but they are not
sure that these are real. Another interesting feature
the comparison has uncovered is a conserved gene
desert.
Anne-Marie Mallon (MRC UK Mouse Genome
Centre) spoke about the UK mouse sequencing
programme (http://mrcseq.har.mrc.ac.uk/). This is a
collaborative effort, the mapping is shared between
the MRC Human Genetics Unit, Imperial College
and the MRC UK Mouse Genome Centre, and the
sequencing is shared by the Wellcome Trust Sanger
Institute and the MRC UK HGMP-RC. The team
have chosen four targeted regions for study, which
match ongoing UK research efforts, including three
major target regions of the MRC ENU mutagenesis
programme. They are still inviting applications for
other regions to cover, until December. The regions
covered so far are the WAGR-homologous region
on chromosome 2, the region around the Tyrp1
(brown) locus on chromosome 4, the Del(13)
Svea36H (Del36H) region of chromosome 13 and
the Dmd to Ar region of chromosome X. The
mapping stage is nearing completion now and they
have produced about half of the sequence. They are
using Ensembl mouse to identify genes and have
already reﬁned the location of several genes. They
are integrating the annotation from human and
mouse Ensembl, and using Fugu rubripes data to
identify upstream regions.
Jim Thomas (NHGRI, USA) presented the large-
scale vertebrate comparative genomics project of the
National Human Genome Research Institute and
the NIH Intramural Sequencing Center. They have
chosen 11 vertebrate species (based on the avail-
ability of BAC resources) for the project: chimp,
baboon, pig, cow, cat, dog, mouse, rat, chicken,
zebraﬁsh and Fugu. They have taken a targeted
approach, picking six regions of interest on human
chromosome 7. For this they design evenly spaced
probes against areas that are highly conserved in
human and mouse. Using these probes they make
BAC maps of each region of interest in each species
and then select orthologous clones for sequencing.
They use Pipmaker for alignments and graphical
representations of data from three genomes at a
time. Ultimately they want to compare all 12
together and are working on a MultiPipmaker
tool. More closely related species (such as cat and
dog and cow and pig) are better at corroborating
matches, whereas less related species show different
patterns of conservation. They plan to extend the
study to more regions and to add more species
(depending on the availability of BAC resources).
In his plenary lecture, Gene Myers (Celera, USA)
spoke about the Celera whole genome assembly for
the mouse. As at February 2000, they have 5.3X
coverage. They have 11.25 million paired end reads
(although some of these are not true, above 90% are
true in each of their three resources). Their
assembler philosophy is to detect and set aside
repeats, and to ﬁrst take advantage of the paired
ends, i.e. they tackle the high conﬁdence steps ﬁrst.
Their tool looks for >40 bp overlaps, allowing
only 6% mismatch, and then constructs overlap
consistent sub-assemblies. Repeat induced errors
amongst these assemblies can be identiﬁed and
discarded, since they are over-represented, often as
much as 15–20X deep, as opposed to the expected
5X. The paired end data is now used to deﬁne
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tigs’, resulting in scaffolds. They require two or
more paired ends joining two unitigs before they are
assigned as a scaffold (Figure 1A). The paired end
data also yields gap size estimates and is used to
help close gaps. This is done by looking for reads
pointing towards a gap and using their mate pairs
(paired ends) to try to ﬁll in the gap (Figure 1B).
Next an STS map is used as an external reference
to check the veracity of the map. They remain
convinced that a 5X mammalian genome can pro-
vide an adequate substrate for annotation. They
tried shredding the Celera and HGP data to make a
new assembly, but the lower quality of the HGP
data caused higher levels of uncertainty in the
assemblies. However, using the 1.7X HGP mouse
data with their human data did improve the
assembly, the span remained essentially the same,
but as less scaffolds, with less gaps. 80% of their
mouse data is in scaffolds >10 Mb in size, with
97% in scaffolds >1 Mb. 50% of the gaps are
<100 bp and there are 72 conﬂicts with the genetic
marker order so far. Comparing human chromo-
some 21 and mouse chromosome 16, the mouse
genome appears to be 10–15% smaller than human.
They have annotated their mouse assembly using
the same tools developed for the human data, which
predict roughly similar numbers of genes for mouse
compared to human, at y30 500 very high con-
ﬁdence predictions rising to y40 500 at a lower
conﬁdence level. They plan to use RIKEN clones
for alternative splicing data.
Functional genomics
Tim Wiltshire (GNF, USA) presented the results of
a large-scale analysis of the mouse transcriptome.
They have used high-density oligonucleotide arrays
to study the expression of 8882 human genes in 46
different tissues and 6139 mouse genes in 45 tissues.
The results for 1800 genes were veriﬁed by RT-PCR
and other genes were checked by Northern blot and
in situ analyses. 90% of the genes gave a signal in at
least one tissue. They have constructed a gene
expression database (http://expression.gnf.org, but
it is not available yet) and have also performed
clustering of genes by their tissue expression
patterns. This has led to the identiﬁcation of
upstream regulatory elements and interesting obser-
vations on the tissue restriction patterns of gene
families. They have deﬁned 799 putative ortholo-
gues between human and mouse, about half of
which show a correlation coefﬁcient of over 0.6 for
their expression. They also observed that some
tissues showed a better overall correlation between
human and mouse.
Lee Smith (MRC Mammalian Genetics Unit)
reported on a microarray screen for genes involved
in mammalian sexual development. They are using
the array to compare male and female embryo
samples; they do four replicates, two with one
colour orientation and two with the reverse colour
orientation. All genes giving interesting results are
checked by in situ analysis to validate the result and
allow observation of timing and cell speciﬁcity of
expression. They have detected know sexually
dimorphic genes and identiﬁed y350 new candi-
dates. However, the technique requires too much
sample (from tiny embryonic organs) for complex
studies such as timecourses to be really feasible, so
they have developed a modiﬁed ampliﬁcation
technique to reduce the quantity of starting material
required. Looking at their overall expression plots,
they do see major differences in each tissue at the
times expected from other studies, and so they feel
that the array data is matching the known biology.
They are now looking at mutants of known and
candidate sexually dimorphic genes.
Harukazu Suzuki (RIKEN, Japan) presented an
analysis of protein-protein interactions detected using
the RIKEN full-length cDNAs. They have used a
PCR-based in vivo screen to detect interactions.
Their 2-hybrid approach is performed in microtitre
plates, giving high-throughput, and each protein is
used as bait and prey giving better conﬁdence in the
Figure 1. Stages in the Celera scaffold assembly process.
A: If two or more paired ends can be used to deﬁne two
contigs as neighbours they become a scaffold. B: The paired
end reads of reads pointing out into gaps are used to help
close gaps. Arrows denote individual reads and dashed lines
identify paired ends, or mate pairs
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one of the known interactions were detected.
6000 cDNAs were chosen for the assay (around
2% of baits had to be discarded), which detected
505 interaction pairs. They have written a program,
called PPI network viewer to handle their data.
Proteins are denoted by circles, joined by arrows
representing the interactions, the thickness of each
arrow being used to denote the strength of the
interaction. The viewer has options to restrict the
level of the network, by the interaction strength or
by the length of links between proteins. The viewer
has links out to expression proﬁles and mapping
data. They expected to see a correlation between the
expression proﬁles of genes they had identiﬁed as
interaction pairs, and there was a signiﬁcant but not
pronounced trend towards this in their data.
However, looking also at data from DIP, they
found that the effect is not enough to allow
prediction of interaction pairs from expression data.
William Stanford (University of Toronto, Canada)
spoke about a large-scale gene trap mutagenesis-
based expression and genotype screen. The tradi-
tional gene trap system works by insertion of a
construct with a splice acceptor site followed by a
promoter-less reporter gene. If the construct inserts
into an intron, the reporter gene shows the expres-
sion pattern of the trapped gene. Vectors that use
splice sites need to trap a downstream poly A tail
signal to work, so they have included a poly A trap
vector, designed to get around this problem, in their
selection of 6 vectors. They have created >5000
trap clones, >4500 have been screened and 3000
have been analysed. They now have funding to
generate sequence tags for all of them, to identify
the position of the insertions. A database is being
created which will allow users to search by expres-
sion pattern, sequence, and phenotype data from
their ongoing screens (http://www.cmhd.ca).
Using puffer ﬁsh DNA sequence to analyse mamma-
lian genomes was the title of Jean Weissenbach’s
(Genoscope, France) plenary lecture. They have
been shotgun sequencing the genome of Tetraodon
nigroviridis, a smaller relative of Fugu rubripes,
which is easier to maintain. They are using a com-
bination of BAC ﬁngerprinting, in situ hybridisation
and STS mapping to build their map. They are also
comparing their data to the human sequence and
other genomes, to identify evolutionarily conserved
regions, which they call ‘ecores’. These are particu-
larly useful for identifying human exons and will
contribute to a deﬁnition of a vertebrate gene set.
Using the initial chromosome 22 data, they esti-
mated that their e-cores detected 66.8% of exons
from known genes, 55.3% of exons from related
genes and 14.8% of exons from predicted genes.
Taking the data from the reannotation of chromo-
some 22, their scores improve to 70%, 60% and 20%
respectively. As of June 2001 they have almost 3X
coverage, assembly of the sequences is still under-
way, but comparison of the new sequences with
human data has given them more ecores. However,
the number of ecores per gene is less in these new
sequences, which he suggests could indicate that
they are now ﬁnding the less well-known genes. The
Whitehead Institute has independently been sequen-
cing the same genome, they have also reached
around 3X coverage, and the two groups have
agreed to combine their data. As yet, they have
made no comparisons to the Fugu rubripes data.
In his plenary lecture, Tim Hubbard (Wellcome
Trust Sanger Institute, UK) discussed the annotation
of vertebrate genome sequences. He spoke about
Ensembl mouse (http://mouse.ensembl.org), which is
very like the human Ensembl resource (http://
www.ensembl.org). It is possible to search against
the mapped clones, the Sanger assembly and the
Whitehead assembly, and the display even includes
the BAC ﬁngerprinting assembly. 71.2% of the
Whitehead assembly has been mapped back onto
the genome, giving ordering and orientation data,
which will lead to a mouse ‘Golden Path’, but this is
not yet available on Ensembl mouse. Their gene
annotation group is currently working on human
chromosomes 6 and 13, and a gene identiﬁcation
group will be sequencing full-length mRNAs across
the whole human genome. Taking their annotation
further includes searching for promoter regions
and he presented a tool called Eponine which
has been written for this purpose (http://servlet.
sanger.ac.uk:8080/eponine/). One feature of Ensembl
that he is keen to promote is the use of a distri-
buted annotation system (DAS, http://biodas.org,
http://www.ensembl.org/das) which allows users to
coordinate synchronisation between distributed
resources and serves your data to other resources
using XML.
Informatics
Deanna Church (NCBI, USA) gave an overview
of the resources for mouse at the NCBI. At the level
of sequence annotation, they are providing data
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GenomeScan models etc. and they are striving
to integrate nomenclature, disease genes, non-
sequence-based maps. They offer multiple query
options, including BLAST searches, text queries
and location-based queries. They offer a range of
maps, the MGI composite map, and the Whitehead
Institute genetic, YAC and radiation hybrid maps
can be displayed using their Map Viewer tool, the
ﬁngerprinting and comparative maps are not yet
on Map Viewer. Their Refseq resource holds
7459 mRNAs and 484 genomic contigs, in addition
they have a huge amount of raw data. Users can
compare human and mouse data and also com-
pare the NCBI and UCSC human assemblies
against mouse data to try to reduce conﬂicts in the
maps.
Carol Bult (The Jackson Laboratory, USA) dis-
cussed their work on integrating computational and
human-curated annotations for the mouse genome.
They have manually curated sets of gene seq-
uences, which could be used to aid computational
annotation, and for validation of the annotation.
She described their infrastructure for combin-
ing these datasets. The ﬁrst stage is a rapid, auto-
mated binning process, based on alignment data
(Figure 2). This separates the entries into genes not
yet represented in one of the resources, unique
genes represented in both resources, and more
complex cases, which will need manual annotation.
Before the inclusion of the FANTOM data, their
Mouse Genome Informatics group (MGI) had
y12 000 genes, after adding the FANTOM data,
they had y24 000 genes and they now have
y40 000 genes (alternate splice forms have been
merged to achieve this number, but there may be
other reasons for the apparent redundancy). They
are also incorporating the RIKEN data into their
analysis, to aid gene detection using the Clone
Curator tool from Berkeley. y50% of the MGI
genes can be associated with an electronic transcript
in the TIGR resource and they are now trying to
link these directly. They are also collaborating with
NCBI and Ensembl for the genome assembly and
data representation and they will be using the
VISTA tool to provide graphical representations
of human-mouse comparisons.
Monica Justice described how to achieve large-
scale isolation and rapid mapping of recessive muta-
tions using a mouse balancer chromosome in her
plenary lecture. Ethylnitrosourea (ENU) causes
point mutations (by alkylating bases in DNA),
which can model the point mutations that cause
human disease. To generate genome-wide muta-
tions, researchers treat the male germline with
ENU, mate these mice and then screen for muta-
tions. Using the Cre-loxP system it is possible to
make inversions, deletions or duplications of parti-
cular regions of the genome, whilst inserting a
reporter gene to visibly tag mutant mice. Using this
strategy with Embryonic Stem (ES) cells, they have
produced a series of deletions and inversions on
chromosome 11 tagged with coat colour markers
(http://www.mouse-genome.bcm.tmc.edu). These can
act as balancer chromosomes in matings with ENU
mutagenised mice. Progeny with a mutated chromo-
some 11 and the balancer are then mated with mice
carrying the balancer. Dominant mutations are
picked up in generation one, recessives in genera-
tion three, which is faster than traditional appro-
aches. If the mutation is lethal, this approach still
yields carriers. They look for visible phenotypes and
perform fertility screens and biochemical tests on
Figure 2. The bins used to sort results from comparing two
resources. A: Genes absent from one or other resource B:
Unique genes represented in both resources C: More
complex situations that are ﬂagged for manual annotation
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identiﬁed >155 recessive mutations, of the 63 they
have mapped so far, 62 are on chromosome 11, as
expected, none are allelic, indicating that they are
far from saturation. Only four show non-Mendelian
inheritance. Of the 39 genetic lethals, 23 die at or
before birth, two die before weaning, six show semi-
viability and eight are sterile. y30 of these are
previously described visible phenotypes from other
genome-wide studies. The lethal mutations can be
good models for haematopoesis and vasculogenesis,
they use the yolk sac as a reporter of blood vessel
development. 11 of the 21 lethal mutations they
have studied in this way die at stage E9.5–12.5,
when the vasculature is developing. One has no
yolk sac vasculature at all.
Mutagenesis
Karen Steel (MRC Institute of Hearing Research,
UK) reported on mouse models for hearing and
balance defects obtained from the European muta-
genesis programmes. First she explained that there
are many forms of human deafness, many of which
have no models. In a three year screening project,
they have tested 53 000 mice, uncovering >50 new
mutants. These were produced 17 of these have
been mapped to a chromosome and six have been
identiﬁed. 8 of the mutants show a novel pheno-
type. Of the three middle ear defects, one is a
mutation in Tcfap2a on mouse chromosome 13.
There are two stereocilia defects and three organ of
corti defects (some of these overlap with other
phenotypes). Of the inner ear defects (all of which
have truncated semicircular canals), two are muta-
tions in the Jag1 gene, and eight are mutations in a
second gene, on chromosome 4. There are also
several progressive hearing loss phenotypes.
Heinrich Flaswinkel (Technical University of
Munich, Germany) spoke about phenotypic analysis
and chromosomal mapping of mouse mutants with
immunological defects caused by ENU mutagenesis.
Their dominant screen involves mating mutagenised
C3H males with females from the same strain. They
use an array of ELISA assays to test the progeny
for levels of a wide range of immune proteins, and
FACS analysis to assess the numbers of each type
of immune cells. They have so far analysed y9000
mice obtaining 54 conﬁrmed mutants. Examples
include a mutant with a four fold reduction in
IgG2a, a mutant with reduced numbers of CD8+
cells, a mutant with elevated IgM levels, and a
mutant whose peripheral CD8+ T-cells are also
CD4+. They have also performed a recessive
screen, in which they have tested 1390 mice (this is
complicated by high rates of infertility). This screen
has identiﬁed more severe mutations, including one
with near complete loss of complement receptor 2
on its B-cells and one with no T-cells at all.
John Schimenti (The Jackson Laboratory, USA)
described their work on mouse infertility and
genome instability mutants. They have used ENU
mutagenesis of males, and of ES cells. Their screens
have identiﬁed mutants in all stages of spermato-
genesis, including meiotic arrests, and mutants with
crucial cell types missing. They also have some
oogenesis mutants. During meiosis, synapses are
formed, proteins accumulate on the chromosome
pairs, holding them together (synaptonemal com-
plex), then DS DNA breaks are formed and ﬁxed,
forming crossovers (recombination). One of their
arrest mutants makes the breaks, but appears to
lack a checkpoint, such that the breaks are not
ﬁxed, causing the arrest. Another shows no pairing
of chromosomes, which leads to a chaotic organisa-
tion of the chromosomes during division. They have
also used a micronucleus assay to ﬁnd mutants
showing genome instability.
Jay Vivian (University of North Carolina, USA)
reported on a genotype-based screen in mouse ES
cells for ENU-induced mutations in the SMAD2
locus. This method allows researchers to identify
unmarked mutations, in ENU-treated ES cells, in
their gene of interest. They treat ES cells with a
regulated dose of ENU. Surviving cells are plated in
duplicate, one plate is used for D-HPLC mutation
detection, the other is stored as a frozen library, for
the subsequent production of chimeric mice. The
SMAD 2 and 4 genes were chosen to test the
approach, as they are expressed in ES cells and not
too big to screen for mutations. They are of interest
as they potentially mediate development and
tumour progression. The SMAD 2 knockout is
lethal at E6.5-7.5 and no proper embryo is formed,
limiting further study. Using this approach, they
have obtained a range of mutants, which they hope
will allow them to learn more about the phenotype,
one in particular does make a badly deformed
embryo, allowing further study of the role of the
gene.
Emma Coghill (MRC Mammalian Genetics Unit,
UK) presented a gene-driven approach to the
identiﬁcation of ENU mutants in the connexin 26
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DNA and sperm archives from ENU mutagenised
mice. The DNA archive was screened for mutations
in the connexin 26 gene (Gjb2, a gap junction
protein linked to hearing loss) and for those
samples showing mutations, the mouse was ‘resur-
rected’ from the sperm archive. In the Gjb2 knock-
out, heterozygotes are normal, but the homozygotes
are lethal hindering further analysis, this tech-
nique generates different types of mutants that
might allow further study. They used Transgenomic
Wave
2 (a mismatch heteroduplex detection sys-
tem) to identify mutants in Gjb2 and then sequen-
ced the gene to see what each mutation was. They
have been able to do limited pooling of the sam-
ples to be analysed, at most they recommend four
into one. They found one mouse carrying a STOP
mutation and used the sperm resource to regain the
mouse. From a cross between its progeny, they were
unable to obtain any homozygotes, but have 37
heterozygotes. They are now searching for other
alleles of this gene and extending their screen to
other cochlear-expressed genes.
Allan Balmain (UCSF, USA) discussed appro-
aches for identifying mouse and human cancer
modiﬁer genes using mouse models. Modiﬁer genes
are host genes that have an effect or tumour
progression. In the case of familial cancer, the host
background has y5% effect (only one ﬁfth of the
breast cancer risk in BRCA families is due to
BRCA. High penetrance genes have a high relative
risk, but are rare, low penetrance (or modiﬁer)
genes can be very common. However, they are
involved in genetic interactions and are very
difﬁcult to map. There could be as many as tens to
hundreds of these modiﬁer genes. So, how do we
ﬁnd them? SNP scans would need y500 000 SNPs
to be genotyped in 1000 cases and controls, which
would cost billions of pounds, so alternative
approaches are needed. His group have a mouse
model of chemically induced skin cancer. Compar-
ing Mus spretus and Mus musculus they saw that
Mus spretus was resistant to the chemical treatment,
and making crosses gave increased susceptibility.
They are now looking for the underlying genes.
Many tumour susceptibility loci have already been
mapped in the mouse, including several for skin
cancer, there are >20 in just one spretus musculus
cross. They try to narrow down regions by sub-
dividing phenotypes, typically they are starting with
10–20 cM regions identiﬁed by linkage analysis.
Making congenic mice and crossing then tracking
down the phenotype is one approach, but this is
very slow and they are exploiting alternatives. They
are looking at outbred mice, making many different
crosses and identifying polymorphisms that are only
present in mice that show linkage. An interspeciﬁc
backcross of these mice with the inbred parent and
mating the progeny of that mating back to the
inbred parent again can separate different outbred
alleles. This approach can get the region down to
y1 cM, at which point they look for candidate
genes in the region and sequence those genes in
(human) individuals to ﬁnd SNPs to test for
association, which then identiﬁes human candidate
genes.
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